AMICUS THERAPEUTICS INC

About

Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering treatments for rare metabolic diseases. The company's portfolio includes therapies for conditions such as Fabry disease and Pompe disease, positioning it as a key player in the specialty pharmaceutical sector. Through its proprietary technology platforms, Amicus aims to address the underlying causes of these genetic disorders and improve patient outcomes.